Advertisement

Use and Outcomes of Multivessel Percutaneous Coronary Intervention in Patients With Acute Myocardial Infarction Complicated by Cardiogenic Shock (from the EHS-PCI Registry)

Published:January 12, 2012DOI:https://doi.org/10.1016/j.amjcard.2011.11.020
      The value of multivessel percutaneous coronary intervention (MV-PCI) in patients with cardiogenic shock (CS) and multivessel disease (MVD) is still unclear because randomized controlled trials are missing. Therefore, we sought to evaluate the impact of MV-PCI on in-hospital outcomes of patients with MVD presenting with CS: 336 patients with acute myocardial infarction complicated by CS and ≥70% stenoses in ≥2 major epicardial vessels were included in this analysis of the Euro Heart Survey PCI registry. Patients undergoing MV-PCI (n = 82, 24%) were compared to those with single-vessel PCI (n = 254, 76%). The rate of 3-vessel disease (60% vs 57%, p = 0.63) was similar in the 2 cohorts. Presentation with resuscitation (48 vs 46%, p = 0.76) and ST-segment elevation myocardial infarction (83 vs 87%, p = 0.31) was frequent in patients with MV-PCI and single-vessel PCI. Patients with ventilation were more likely to receive MV-PCI (30% vs 19%, p = 0.05). There was a tendency toward a higher hospital mortality in patients with MV-PCI (48.8% vs 37.4%, p = 0.07). After adjustment for confounding variables, no significant difference for in-hospital mortality (odd ratio [OR] 1.28, 95% confidence interval [CI] 0.72 to 2.28) could be observed between the 2 groups. Age (OR 1.41, 95% CI 1.13 to 1.77), 3-vessel disease (OR 1.78, 95% CI 1.04 to 3.03), ventilation (OR 3.01, 95% CI 1.59 to 5.68), and previous resuscitation (OR 2.55, 95% CI 1.48 to 4.39) were independent predictors of hospital death. In conclusion, MV-PCI is currently used in only 1/4 of patients with CS and MVD. An additional nonculprit PCI was not associated with a survival benefit in these high risk patients.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Conde-Vela C.
        • Moreno R.
        • Hernández R.
        • Pérez-Vizcayno M.J.
        • Alfonso F.
        • Escaned J.
        • Sabaté M.
        • Bañuelos C.
        • Macaya C.
        Cardiogenic shock at admission in patients with multivessel disease and acute myocardial infarction treated with percutaneous coronary intervention: related factors.
        Int J Cardiol. 2007; 123: 29-33
        • Hochman J.S.
        • Buller C.E.
        • Sleeper L.A.
        • Boland J.
        • Dzavik V.
        • Sanborn T.A.
        • Godfrey E.
        • White H.D.
        • Lim J.
        • LeJemtel T.
        Cardiogenic shock complicating acute myocardial infarction—etiologies, management and outcome: a report from the SHOCK trial registry.
        J Am Coll Cardiol. 2000; 36: 1063-1070
        • Hochman J.S.
        • Sleeper L.A.
        • Webb J.G.
        • Sanborn T.A.
        • White H.D.
        • Talley J.D.
        • Buller C.E.
        • Jacobs A.K.
        • Slater J.N.
        • Col J.
        • McKinlay S.M.
        • LeJemtel T.H.
        Early revascularization in acute myocardial infarction complicated by cardiogenic shock.
        N Engl J Med. 1999; 341: 625-634
        • Santoro G.M.
        • Buonamici P.
        Reperfusion therapy in cardiogenic shock complicating acute myocardial infarction.
        Am Heart J. 1999; 138: S126-S131
        • White H.D.
        • Assmann S.F.
        • Sanborn T.A.
        • Jacobs A.K.
        • Webb J.G.
        • Sleeper L.A.
        • Wong C.K.
        • Stewart J.T.
        • Aylward P.E.
        • Wong S.C.
        • Hochman J.S.
        Comparison of percutaneous coronary intervention and coronary artery bypass grafting after acute myocardial infarction complicated by cardiogenic shock: results from the Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock (SHOCK) trial.
        Circulation. 2005; 112: 1992-2001
        • Muller D.W.
        • Topol E.J.
        • Ellis S.G.
        • Sigmon K.N.
        • Lee K.
        • Califf R.M.
        Multivessel coronary artery disease: a key predictor of short-term prognosis after reperfusion therapy for acute myocardial infarction.
        Am Heart J. 1991; 121: 1042-1049
        • Sanborn T.A.
        • Sleeper L.A.
        • Webb J.G.
        • French J.K.
        • Bergman G.
        • Parikh M.
        • Wong S.C.
        • Boland J.
        • Pfisterer M.
        • Slater J.N.
        • Sharma S.
        • Hochman J.S.
        • SHOCK Investigators
        Correlates of one-year survival inpatients with cardiogenic shock complicating acute myocardial infarction: angiographic findings from the SHOCK trial.
        J Am Coll Cardiol. 2003; 42: 1373-1379
        • Webb J.G.
        • Sanborn T.A.
        • Sleeper L.A.
        • Carere R.G.
        • Buller C.E.
        • Slater J.N.
        • Baran K.W.
        • Koller P.T.
        • Talley J.D.
        • Porway M.
        • Hochman J.S.
        • SHOCK Investigators
        Percutaneous coronary intervention for cardiogenic shock in the SHOCK Trial Registry.
        Am Heart J. 2001; 141: 964-970
        • Wong S.C.
        • Sanborn T.
        • Sleeper L.A.
        • Webb J.G.
        • Pilchik R.
        • Hart D.
        • Mejnartowicz S.
        • Antonelli T.A.
        • Lange R.
        • French J.K.
        • Bergman G.
        • LeJemtel T.
        • Hochman J.S.
        Angiographic findings and clinical correlates in patients with cardiogenic shock complicating acute myocardial infarction: a report from the SHOCK trial registry.
        J Am Coll Cardiol. 2000; 36: 1077-1083
        • Zeymer U.
        • Vogt A.
        • Zahn R.
        • Weber M.A.
        • Tebbe U.
        • Gottwik M.
        • Bonzel T.
        • Senges J.
        • Neuhaus K.L.
        • Arbeitsgemeinschaft Leitende Kardiologische Krankenhausärzte (ALKK)
        Leitende Predictors of in-hospital mortality in 1333 patients with acute myocardial infarction complicated by cardiogenic shock treated with primary percutaneous coronary intervention (PCI); Results of the primary PCI registry of the Arbeitsgemeinschaft Leitende Kardiologische Krankenhausärzte (ALKK).
        Eur Heart J. 2004; 25: 322-328
        • Silber S.
        • Albertsson P.
        • Avilés F.F.
        • Camici P.G.
        • Colombo A.
        • Hamm C.
        • Jørgensen E.
        • Marco J.
        • Nordrehaug J.E.
        • Ruzyllo W.
        • Urban P.
        • Stone G.W.
        • Wijns W.
        Guidelines for percutaneous coronary interventions.
        Eur Heart J. 2005; 26: 804-847
        • Thiele H.
        • Allam B.
        • Chatellier G.
        • Schuler G.
        • Lafont A.
        Shock in acute myocardial infarction: the Cape horn for trials?.
        Eur Heart J. 2010; 31: 1828-1835
        • van der Schaaf R.J.
        • Claessen B.E.
        • Vis M.M.
        • Hoebers L.P.
        • Koch K.T.
        • Baan Jr, J.
        • Meuwissen M.
        • Engstrom A.E.
        • Kikkert W.J.
        • Tijssen J.G.
        • de Winter R.J.
        • Piek J.J.
        • Henriques J.P.
        Effect of multivessel coronary disease with or without concurrent chronic total occlusion on one-year mortality in patients treated with primary percutaneous coronary intervention for cardiogenic shock.
        Am J Cardiol. 2010; 105: 955-959
        • Webb J.G.
        • Lowe A.M.
        • Sanborn T.A.
        • White H.D.
        • Sleeper L.A.
        • Carere R.G.
        • Buller C.E.
        • Wong S.C.
        • Boland J.
        • Dzavik V.
        • Porway M.
        • Pate G.
        • Bergman G.
        • Hochman J.S.
        • SHOCK Investigators
        Percutaneous coronary intervention for cardiogenic shock in the SHOCK trial.
        J Am Coll Cardiol. 2003; 42: 1380-1386
        • Webb J.G.
        • Sleeper L.A.
        • Buller C.E.
        • Boland J.
        • Palazzo A.
        • Buller E.
        • White H.D.
        • Hochman J.S.
        Implications of the timing of onset of cardiogenic shock after acute myocardial infarction: a report from the SHOCK trial registry.
        J Am Coll Cardiol. 2000; 36: 1084-1090
        • Beyersdorf F.
        • Acar C.
        • Buckberg G.D.
        • Partington M.T.
        • Sjöstrand F.
        • Young H.H.
        • Bugyi H.I.
        • Okamoto F.
        • Allen B.S.
        Studies on prolonged acute regional ischemia.
        J Thorac Cardiovasc Surg. 1989; 98: 368-380
        • Grines C.L.
        • Topol E.J.
        • Califf R.M.
        • Stack R.S.
        • George B.S.
        • Kereiakes D.
        • Boswick J.M.
        • Kline E.
        • O'Neill W.W.
        Prognostic implications and predictors of enhanced regional wall motion of the noninfarct zone after thrombolysis and angioplasty therapy of acute myocardial infarction.
        Circulation. 1989; 80: 245-253
        • Ambrose J.A.
        • Weinrauch M.
        Thrombosis in ischemic heart disease.
        Arch Intern Med. 1996; 156: 1382-1394
        • Barrett T.D.
        • Hennan J.K.
        • Marks R.M.
        • Lucchesi B.R.
        C-reactive-protein-associated increase in myocardial infarct size after ischemia/reperfusion.
        J Pharmacol Exp Ther. 2002; 303: 1007-1013
        • Mehta R.H.
        • Ou F.S.
        • Peterson E.D.
        • Shaw R.E.
        • Hillegass Jr, W.B.
        • Rumsfeld J.S.
        • Roe M.T.
        Clinical significance of post-procedural TIMI flow in patients with cardiogenic shock undergoing primary percutaneous coronary intervention.
        JACC Cardiovasc Interv. 2009; 2: 56-64
        • Hanratty C.G.
        • Koyama Y.
        • Rasmussen H.H.
        • Nelson G.I.
        • Hansen P.S.
        • Ward M.R.
        Exaggeration of nonculprit stenosis severity during acute myocardial infarction: implications for immediate multivessel revascularization.
        J Am Coll Cardiol. 2002; 40: 911-916